New Study with Lee Women’s Hospital and Chung Shan University Demonstrates Promising Findings for ora® Endometrial Receptivity Test

A recent study and subsequent publication done in partnership with Lee Women’s Hospital and Chung Shan University has yielded promising results in regard to ora® Non-Invasive Endometrial Receptivity Test.


The paper highlights three key points that support blood-based miRNA analysis:

  • The authors demonstrated that plasma miRNAs change dynamically across the peri-implantation window. This supports the idea that blood contains time-sensitive biological information relevant to endometrial receptivity.
  • Although plasma and endometrial tissue do not share completely identical miRNAs, they do converge at the level of functional pathways such as apoptosis, cell cycle, aging, inflammation, and lipid metabolism. This is important because it argues that a blood test does not need to be a perfect molecular copy of an endometrial biopsy to still be biologically meaningful.
  • Four miRNAs showed concordant temporal trends in tissue and plasma, which suggests at least partial cross-compartment tracking of implantation biology.

Why this matters for ora® Non-Invasive Endometrial Receptivity Test:

Receptivity biology is detectable systemically, not only in endometrial tissue. Peripheral blood biomarkers can reflect the implantation window, even if the exact molecules differ from biopsy-based markers. It is best understood as ready a pathway-level physiological state, rather than replicating tissue biopsy markers one-to-one.



Further details and implications of the study Takeaway
The paper studies the P+3 to P+7 implantation window and show dynamic regulation over time Endometrial receptivity is a time dependent biological state
Seventeen plasma miRNAs changed significantly across the same window The above-mentioned dynamics are visible in plasma
Shared enriched pathways include apoptosis, cell cycle, aging, inflammation, and lipid metabolism Plasma and the endometrium converge on the same receptive biology.
The assay does not need to reproduce endometrial tissue biopsy biomarkers exactly to capture the same functional state. A blood-based test like ora® is biologically plausible.

Read the full article here.